HEALEY ALS Platform Trial - Regimen D Pridopidine

Clinical trial NCT04615923 · COMPLETED

Trial details

NCT number: NCT04615923
Sponsor: Merit E. Cudkowicz, MD
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2020-12-18
Primary completion: 2022-07-14
Enrollment: 163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.